Improved prognosis by trastuzumab of women with HER2-positive breast cancer compared with those with HER2-negative disease.

MLA

Ferretti, Gianluigi, et al. “Improved Prognosis by Trastuzumab of Women with HER2-Positive Breast Cancer Compared with Those with HER2-Negative Disease.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 28, no. 20, July 2010, p. e337. EBSCOhost, https://doi.org/10.1200/JCO.2010.28.2525.

APA

Ferretti, G., Fabi, A., Felici, A., & Papaldo, P. (2010). Improved prognosis by trastuzumab of women with HER2-positive breast cancer compared with those with HER2-negative disease. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 28(20), e337. https://doi.org/10.1200/JCO.2010.28.2525

Chicago

Ferretti, Gianluigi, Alessandra Fabi, Alessandra Felici, and Paola Papaldo. 2010. “Improved Prognosis by Trastuzumab of Women with HER2-Positive Breast Cancer Compared with Those with HER2-Negative Disease.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 28 (20): e337. doi:10.1200/JCO.2010.28.2525.